Upgrade

Sonoma Pharmaceuticals, Inc.

SNOA

Last
$1.23
Day
+6.0%
1y
-73.5%
5y
-98.9%
52w
-73.9%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0324d
EMA 21
1.24
EMA 50
1.26
EMA 200
1.82
20d high
-13.4%
5y high
-99.2%
5y range
0th
Website · 10 employees · United States

Positions held

Your positions

SNOA isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
-33
Hold
avoid
Signal
Strong Sell
Target
$1.27
Stop
$1.07
Stop distance
13.0%
Target vs last
+3.3%

Fundamentals

Market cap$5.55MEnterprise value$955,573Trailing P/E—Forward P/E-2.07
PEG1.08Price / book0.84Beta1.30Dividend yield0.00%
Revenue growth59.6%Earnings growth—Gross margin38.9%Operating margin-0.6%
Profit margin-10.3%ROE-42.5%ROA-5.4%Debt / equity0.11
Current ratio2.99Free cash flow-$1.47MAnalyst recommendationnoneMean target—
52w high$4.3052w low$0.85

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q2
Revenue$6.4M$5.6M$4.3M$5.6M$4.0M
Op margin-0.6%-6.3%-15.6%-6.0%-27.3%
Net income-$0.3M-$0.6M-$0.8M-$0.5M-$1.2M
Gross margin40.2%39.2%37.9%37.8%36.5%
Gross profit$2.6M$2.2M$1.6M$2.1M$1.5M
Operating income-$0.0M-$0.4M-$0.7M-$0.3M-$1.1M
  • Revenue +15% vs prior quarter ($6.4M vs $5.6M).
  • Gross margin 40.2% (was 39.2% prior quarter).
  • Operating margin expanded to -0.6%.

Yearly (6y)

20262025202420232022
Revenue$19.5M$14.3M$12.7M$13.3M—
Op margin-12.6%-26.0%-36.9%-34.4%—
Net income-$3.2M-$3.5M-$4.8M-$5.2M—
Gross margin38.0%38.2%37.3%33.7%—
Gross profit$7.4M$5.5M$4.7M$4.5M—
Operating income-$2.5M-$3.7M-$4.7M-$4.6M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

SNOA · daily-10.4% over 13 sessions
Close EMA21 EMA50 EMA200
1.131.181.231.271.322026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$1M$1M$3M$4M$6M-27%6%40%2025-Q22025-Q32025-Q42026-Q12026-Q2